Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

First Light Announces Company Name Change

First Light Diagnostics
Posted on: 07 Jan 19
First Light Announces Company Name Change

PR Newswire

CHELMSFORD, Mass., Jan. 7, 2019

CHELMSFORD, Mass., Jan. 7, 2019 /PRNewswire/ -- First Light Biosciences, a developer of breakthrough automated products for rapid, sensitive, and cost-effective diagnosis of life-threatening antibiotic-resistant infections, today announced that effective immediately, the company is changing their name to First Light Diagnostics. The new name reflects the company's evolution from development to commercialization of diagnostic solutions.

"This name change is an important next step for our company," said David Macdonald, CEO of First Light Diagnostics. "The company name First Light Diagnostics is more clearly aligned with our company's mission, to deliver highly differentiated diagnostic solutions for pathogen detection and antibiotic susceptibility testing for antibiotic-resistant infections."

In addition to their new corporate name, the company has also introduced a new web address and updated website. First Light Diagnostics can now be found at www.firstlightdx.com.

About First Light Diagnostics

First Light Diagnostics is developing and preparing to commercialize, innovative diagnostic products for rapid, sensitive and cost-saving detection of life-threatening infections, and combating the spread of antibiotic resistance. Don Straus is the company's Founder and primary inventor of the company's core scientific technology. Based on its proprietary MultiPath™ detection technology, First Light's products combine the clinical performance of the most advanced commercial laboratory tests with speed, cost-effectiveness, and ease-of-use. The tests rapidly detect infections, identify infectious agents, and determine effective targeted antibiotic therapy. This will improve patient outcomes, reduce healthcare costs, and prevent inappropriate use of powerful antibiotics. To learn more, please visit: www.firstlightdx.com

David Macdonald
President and CEO
First Light Diagnostics
dmacdonald@firstlightdx.com
Mobile: (858) 997-9641

View original content to download multimedia:http://www.prnewswire.com/news-releases/first-light-announces-company-name-change-300773411.html

SOURCE First Light Diagnostics

PR Newswire
www.prnewswire.com

Last updated on: 07/01/2019

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.